Systemic primary carnitine deficiency

Primary systemic carnitine deficiency (PSCD) is an autosomal recessive inherited disorder of the carnitine cycle. It is caused by pathogenic variants in the SLC22A5 gene, which reduce the function of the OCTN2 transporter. This leads to very low levels of carnitine in plasma and tissues, compromising energy production from fatty acids, especially in the heart, skeletal muscle, and liver.

The SLC22A5 gene encodes the OCTN2 transporter (Organic Cation Transporter Novel 2), responsible for introducing L-carnitine into cells and reabsorbing it in the kidney to prevent urinary loss. This function is particularly important in tissues with high energy demands, such as the heart, skeletal muscle, liver, and kidneys.

Carnitine allows the transport of long-chain fatty acids into the mitochondria, where they are oxidized to produce energy. When pathogenic biallelic variants exist in SLC22A5, the transporter functions poorly or is absent, carnitine is lost via the kidneys, and its availability in tissues is markedly reduced. Consequently, the body cannot utilize fats well during fasting or infections, which favors hypoketotic hypoglycemia, myopathy, and cardiomyopathy. DSP is inherited in an autosomal recessive pattern. Its incidence varies between populations and newborn screening programs; it is particularly common in the Faroe Islands, and high frequencies have also been described in some regions of Asia due to recurrent or founder variants.

Symptoms

The clinical presentation is variable. In infants and young children, metabolic crises triggered by fasting or infections may appear, with poor feeding, lethargy, irritability, hepatomegaly, elevated transaminases, hyperammonemia, and hypoketotic hypoglycemia. In childhood, it can also present with myopathy, muscle weakness, increased creatine kinase, and dilated cardiomyopathy, which can cause arrhythmias or sudden death if untreated. Some adults present with fatigue, arrhythmias, or remain asymptomatic, and may be identified after neonatal screening of a child with low carnitine.

Disease management

Management is very effective when initiated early. The main treatment is chronic oral supplementation with L-carnitine, adjusted according to plasma levels and tolerance, to restore carnitine availability and prevent irreversible cardiac, muscular, and metabolic damage. Furthermore, it is recommended to avoid prolonged fasting, ensure carbohydrate intake during illnesses or procedures, and administer intravenous glucose if oral intake is not tolerated. Monitoring includes checks of plasma carnitine, growth and development, transaminases, creatine kinase, and periodic cardiological evaluation with ECG and echocardiogram.

Genes analyzed

SLC22A5 U
U Ultra Whole Genome Sequencing 30x

Bibliography

Chen Y, Lin Q, Zeng Y, et al. Gene spectrum and clinical traits of 10 patients with primary carnitine deficiency. Mol Genet Genomic Med. 2021 Feb;9(2):e1583.

Crefcoeur LL, Visser G, Ferdinandusse S, et al. Clinical characteristics of primary carnitine deficiency: A structured review using a case-by-case approach. J Inherit Metab Dis. 2022 May;45(3):386-405.

El-Hattab AW, Scaglia F. Disorders of carnitine biosynthesis and transport. Mol Genet Metab. 2015 Nov;116(3):107-12.

Lin Y, Lin B, Chen Y, et al. Biochemical and genetic characteristics of patients with primary carnitine deficiency identified through newborn screening. Orphanet J Rare Dis. 2021 Dec 4;16(1):503.

Rasmussen J, Nielsen OW, Janzen N, et al. Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands. J Inherit Metab Dis. 2014 Mar;37(2):215-22.

What do your genes say about you? Start your journey today.

Get a special 5% discount on your first kit.

Haven't you taken our DNA test yet?

Get your genetic test and discover what your DNA says about you.

pack
Starter DNA test
The best option to get started

Ancestry service, Traits and Wellness

Buy
pack
DNA test Advanced DNA test
Know your DNA in depth

Health, Ancestry service, Traits and Wellness

Buy
pack
Genetic analysisUltra
Whole Genome Sequencing 30x

Health, Ancestrality, Traits and Wellness

includes three months of tellmeGen+

Buy

Important information and limitations

Europe
Austria
Belgium
Czech Republic
Denmark
Finland
Germany
Hungary
Ireland
Italy
Netherlands
Norway
Poland
Portugal
Romania
Spain
Sweden
Switzerland
United Kingdom
Asia
Kazakhstan
Saudi Arabia
UAE
America
Brazil
Canada
Chile
Colombia
Mexico
Panama
Peru
United States
Oceania
Australia
The Best Prices of the Year! Only until November 27 Use our coupon BLACK15
Buy